Medical Device News Magazine

Gayle Sheppard is Appointed to the NovaSignal Advisory Board

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

September 11, 2020

Gayle Sheppard has been appointed to the NovaSignal advisory board.

Gayle Sheppard is a global technology entrepreneur and leader with a proven track record of scaling small- and medium-sized companies to a market-leading position. As Chairman and CEO of Saffron Technology, Inc., a predictive reasoning solution for enterprise decision making, Sheppard successfully grew the business to $20M in revenue and an acquisition in 2015 by Intel, where she continued to lead the business through 2018. Currently, Sheppard serves as Corporate Vice President of Azure Data at Microsoft, where she is responsible for the vision, strategy, and long-range P&L for growing Microsoft’s Cloud Services with customers who are implementing multiyear digital innovation and modernization strategies.

Earlier in her career, Sheppard held the role of Vice President and Managing Director at PeopleSoft and served as CEO and President of MarketMile (now part of Rearden Commerce), where she led the development and launch of a software-as-a-service e-procurement business for American Express.

“Gayle’s global experience in successfully building companies – specifically those fueled by artificial intelligence – will be invaluable as we scale to meet the growing demand and extend the reach and impact of our solutions worldwide. I personally look forward to benefiting from her relevant expertise and advice,” said Diane Bryant, Chairman and CEO of NovaSignal.

“I am honored and excited to join such a strong team of technology leaders with the vision of ending brain disease through cerebral blood flow analysis,” said Sheppard. “With Saffron I built a team and business that solved real world problems and delivered shareholder value. To work with NovaSignal in achieving industry leadership is a great honor.”

Sheppard is a graduate of the University of South Florida, where she received a B.S. in Business Administration with a focus in operations research and management science.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”